Guangzhou Jinqirui Biotechnology Co., Ltd. (referred to as "Jinqirui") was established in 2016, focusing on the research and development, production, and sales of precision medical in vitro diagnostic products. It is committed to meeting various clinical application needs and providing truly localized precision molecular diagnostic overall solutions applicable to various medical institutions. Jinqirui has independently developed multiplex PCR and ultra multiplex targeted sequencing based on independent innovation